Vanhoutte, F., Mazur, M., Voloshyn, O., Stanislavchuk, M., Van der Aa, A., Namour, F., . . . van 't Klooster, G. (2017). Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Filgotinib, a Selective JAK‐1 Inhibitor, After Short‐Term Treatment of Rheumatoid Arthritis: Results of Two Randomized Phase IIa Trials. Arthritis Rheumatol.
Citação norma ChicagoVanhoutte, Frédéric, Minodora Mazur, Oleksandr Voloshyn, Mykola Stanislavchuk, Annegret Van der Aa, Florence Namour, René Galien, Luc Meuleners, and Gerben van 't Klooster. "Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Filgotinib, a Selective JAK‐1 Inhibitor, After Short‐Term Treatment of Rheumatoid Arthritis: Results of Two Randomized Phase IIa Trials." Arthritis Rheumatol 2017.
Citação norma MLAVanhoutte, Frédéric, et al. "Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Filgotinib, a Selective JAK‐1 Inhibitor, After Short‐Term Treatment of Rheumatoid Arthritis: Results of Two Randomized Phase IIa Trials." Arthritis Rheumatol 2017.